Security key
02262M605
Alzamend Neuro, Inc. - Common Stock, par value $0.0001 per share (ALZN)
CUSIP: 02262M605
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 2,184
- Total 13F value
- $6,355
- Share change
- +2,184
- SEC-reported price per share
- $2.91
- Number of holders
- 7
- Value change
- +$6,355
- Number of buys
- 7
- Shares outstanding
- 3,793,386
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
7
Top holders
7
ALZN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Alzamend Neuro, Inc. SEC filings
Alzamend Neuro, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02262M605
Recent filing periods:
Ownership snapshot
Top reported holders of ALZN - Alzamend Neuro, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Andrew H. Woo
Disclosed value leader
Andrew H. Woo
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5
13F
Highest disclosed value: $101,850
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Andrew H. Woo has the largest disclosed position value at $101.8K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Andrew H. Woo's linked filing trail.
Disclosed position value
Top 5
Andrew H. Woo
$101.8K
Jeffrey Oram
$101.8K
Mark Gustafson
$61.1K
Stephan Jackman
$46.3K
GEODE CAPITAL MANAGEMENT, LLC
$37.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Andrew H. Woo |
3/4/5
Director
|
—
class O/S missing
|
$101,850
100,000 shares
|
— | 15 Mar 2022 |
| Jeffrey Oram |
3/4/5
Director
|
—
class O/S missing
|
$101,850
100,000 shares
|
— | 15 Mar 2022 |
| Mark Gustafson |
3/4/5
Director
|
—
class O/S missing
|
$61,110
60,000 shares
|
— | 31 Mar 2022 |
| Stephan Jackman |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$46,342
45,500 shares
|
— | 28 Apr 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$37,128
39,152 shares
|
— | 31 Mar 2025 |
| TRUIST FINANCIAL CORP |
13F
Company
|
—
class O/S missing
|
$14,697
15,498 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
2,184
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2026 Across Filers
Q1 2026 holders
12
Q2 2025 holders
7
Holder diff
-5
| Investor | Q1 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend